Chembio Diagnostics (CEMI) Reports Q2 GAAP Loss of $0.86/Share

August 11, 2016 8:34 AM EDT
Get Alerts CEMI Hot Sheet
Trade CEMI Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Chembio Diagnostics (NASDAQ: CEMI) reported Q2 EPS of ($0.86), versus ($0.07) reported last year. Revenue for the quarter came in at $3.27 million, versus $6.72 million reported last year.

The net loss in the 2016 period includes a tax provision for the recording of a valuation allowance on the Company's deferred tax asset of $5,963,000.

For earnings history and earnings-related data on Chembio Diagnostics (CEMI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment